Fresenius | FRE - Passivo Circulante





Passivo Circulante Alterar Data
Akzo Nobel EUR 4.31B 77M 2026-06
Alcon AG USD 3B 45M 2026-03
AstraZeneca USD 31.55B 1.02B 2026-06
BASF EUR 20.91B 1.26B 2026-06
Bayer EUR 33.46B 875M 2026-03
Beiersdorf EUR 3.51B 261M 2025-12
DaVita Healthcare Partners USD 2.86B 12.03M 2026-06
Demant DKK 7.42B 1.63B 2025-12
E.ON EUR 29.49B 1.4B 2026-03
Essilor EUR 12.64B 490M 2026-06
Fresenius EUR 8.38B 1.18B 2025-12
Fresenius Medical Care EUR 6.73B 484.42M 2026-03
Getinge SEK 12.03B 3.01B 2026-06
Givaudan CHF 2.35B 422M 2025-12
GlaxoSmithKline GBP 21.53B 895M 2026-06
GN Store Nord DKK 4.81B 2.5B 2026-03
GRIFOLS EUR 2.24B 112M 2026-06
Hikma Pharmaceutical USD 1.45B 603M 2025-12
Lonza CHF 3.57B 421M 2025-12
Merck EUR 9.35B 307M 2026-03
Novartis USD 31.75B 374M 2026-06
Philips EUR 7.42B 8M 2026-06
Roche Holding CHF 28.85B 846M 2026-06
RWE EUR 36.24B 13.31B 2026-03
Sanofi EUR 31.93B 1.92B 2026-06
Smith & Nephew USD 2.05B 510M 2026-06